Open original FDA record ↗Recall record
- FDA identifier
- Z-1933-2024
- Company in FDA record
- Reflexion Medical, Inc.
- FDA classification date
- May 30, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.
Source facts
- Action
- On 04/29/2024, the firm sent an "Urgent: Medical Device Recall Safety Notification" via email to customer informing them that during internal dosimetric testing of SCINTIX OOS partials in periodic tracking mode, it was observed that the delivered dose error of the full fraction can exceed 5% with respect to the upper bound of one or more static volumes within the DVH in the plan (non-tracked, non-target volumes in the patient frame of reference, i.e., the planning CT). This was determined to be the result of a software defect associated with completing interrupted. Customers are instructed to: 1. Notify all clinical staff of this recall 2. Utilized the Clinical Guidance Document that is include with this notification. For questions or concerns - contact Service and Support at 650-239-9070 or email support@reflexion.com
- Initiated
- 2024-04-16
- Root cause
- Software design
- Distribution
- U.S.: CA, CT, NJ, OR, PA and TX No O.U.S.
- Recall number
- Z-1933-2024
- Recall status
- Open, Classified
- CDRH record ID
- 207500
- FDA classified
- 2024-05-30
- Recall event number
- 94533